Neurology News Network for the week ending June 8, 2019.
News
Advertisement
Advertisement
Advertisement
Advertisement
The FDA has approved an sBLA for deflazacort that expands the label to patients aged 2 to 5 with Duchenne muscular dystrophy.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Earlier Pimavanserin Initiation May Alter Psychosis Symptom Trajectory in Parkinson's Disease, Exploratory Analysis Suggests
2
Real-World Survey Data Suggest Deutetrabenazine May Improve Quality of Life Measures in Huntington Disease Chorea
3
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
4
Using Social Connection as “Medicine” in Parkinson Disease Care: Robert Cochrane, PhD
5